KemPharm, Inc. (Nasdaq: KMPH) announced that its Investigational New Drug (IND) application for KP415 has been accepted by the U.S ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE